JFGIW
RDY icon

Johnson Financial Group Inc (Wisconsin)’s Dr. Reddy's Laboratories RDY Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-60
Closed -$1K – 787
2021
Q4 		$1K Sell
60
-60
-50% -$756 ﹤0.01% 746
2021
Q3 		$2K Hold
120
– – ﹤0.01% 652
2021
Q2 		$2K Buy
+120
New +$1.68K ﹤0.01% 661

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s RDY Position: Q1 2022 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Dr. Reddy's Laboratories (RDY) in Q1 2022, closing a stake of 60 shares — an estimated $1K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in RDY in Q2 2021 and held it in 3 quarters. The position peaked at $2K in Q3 2021. 145 funds tracked by Wall St. Rank hold RDY as of Q1 2022.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Dr. Reddy's Laboratories position as of Q1 2022 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 60 Dr. Reddy's Laboratories shares in Q1 2022, an estimated $1K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Dr. Reddy's Laboratories in Q2 2021 and held it in 3 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Dr. Reddy's Laboratories position peaked at $2K in Q3 2021.
  • 145 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2022.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2022, filed 16 May 2022.